about
Evaluation of the influence of formulation and process variables on mechanical properties of oral mucoadhesive films using multivariate data analysis.Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazamFast dissolving strips: A novel approach for the delivery of verapamil.Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.Development and validation of reversed-phase high-performance liquid chromatography method for estimation of rizatriptan benzoate in oral strip formulations.Characterization and optimization of orodispersible mosapride film formulations.Characterization of oral disintegrating film containing donepezil for Alzheimer disease.Formation of Organic Molecular Nanocrystals under Soft Confinement.Oral buccoadhesive films of ondansetron: Development and evaluationOrally dissolving strips: A new approach to oral drug delivery system.Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.Advances in orodispersible films for drug delivery.Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.Recent developments in buccal and sublingual delivery systems.Oromucosal film preparations: points to consider for patient centricity and manufacturing processes.Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.Formulation and characterization of acetaminophen nanoparticles in orally disintegrating films.A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.Quality of life in patients with recurrent aphthous stomatitis treated with a mucoadhesive patch containing citrus essential oil.In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids.Challenges and Opportunities in the Development of HIV Medications in Pediatric Patients.Formulation development and evaluation of zolmitriptan oral soluble films using 22 factorial designs.Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine Nanocomposites as Innovative Biomaterials for Treatment of Oral Infections.Effect of novel mucoadhesive buccal patches of carvedilol on isoprenaline-induced tachycardia.The influence of recrystallized caffeine on water-swellable polymethacrylate mucoadhesive buccal films.Formulation of Novel Layered Sodium Carboxymethylcellulose Film Wound Dressings with Ibuprofen for Alleviating Wound PainCritical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.Formulation, characterisation and stabilisation of buccal films for paediatric drug delivery of omeprazole.Using USP I and USP IV for discriminating dissolution rates of nano- and microparticle-loaded pharmaceutical strip-films.Formulation, optimization and evaluation of levocetirizine dihyrochloride oral thin strip.Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability.Mucoadhesive buccal patches based on interpolymer complexes of chitosan-pectin for delivery of carvedilol.Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.Buccal films of prednisolone with enhanced bioavailability.Development of a buccal mucoadhesive film for fast dissolution: mathematical rationale, production and physicochemical characterization.A new method for evaluating the dissolution of orodispersible films.Novel delivery approach for ketotifen fumarate: dissofilms formulation using 3² experimental design: in vitro/in vivo evaluation.Formulation and optimization of duloxetine hydrochloride buccal films: in vitro and in vivo evaluation.Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
P2860
Q30843550-FEB112C9-1689-4160-BCDC-51E984ECF1EAQ34330138-E96B8F62-71DE-4E8B-9E15-D6D72FCFD1C7Q34373809-BEF0E3F7-5CD8-4AA7-947B-0A04A17E349FQ34712836-E479DBFC-AC49-42A6-97C2-EF7FA9EB6369Q34719677-59D5BD6F-965A-49CA-9CAA-5EC6EFC3A41AQ35577232-8A1F6AE6-58F4-4E4B-AB7F-364E866DF551Q35821872-02507C67-588D-4B0F-9A57-9DB28C524869Q35981768-1CE58BB9-46DC-44E4-B9BA-4F2B9AB6A058Q37133939-5FA8B168-7220-4B26-A812-7F8C0D083090Q37133942-20F71995-0D2B-454F-844A-48FE55333A95Q37158884-7A50E45A-0C52-404A-AE96-F57D9E3CC771Q37834030-626F96C2-71B3-4547-818D-0B18C0A709E3Q37976848-26F5AA93-0FBB-4586-AB4B-A1B210349D5CQ38003422-59C30769-0CA7-4EFD-B38C-501ED8D8BCA2Q38630904-B859C465-7E2D-497B-9F70-1CD3ED87A0E2Q38896329-AB9EE876-BAB4-4A84-86C8-680B19C865F6Q39161319-77CCF421-01EB-4BA3-9A59-73F0DA6987EDQ39177332-2F29AAF1-2325-4770-8BE8-0A201D885893Q39676225-430F01BB-19BD-4511-9F04-2DAFBFD27F0FQ39934188-3F273304-1704-4F68-A2D9-66E54EA8BF78Q40377157-20F0D1D2-B40F-4B44-BD68-8D769573663BQ40463924-DB60BABA-961F-4FE5-A53C-0A9523A87F2CQ40638587-88EF25A0-07F5-4F3D-B08D-B143C674F3B1Q40952849-789BD55F-C845-454C-8098-4F72F4716FE2Q41125434-0C4C1804-DECE-41B1-918E-2A50842C110CQ41461997-23C74CA0-520C-400D-9DFE-7A20806D0E4AQ41713132-C73069EA-852F-49E4-9C09-43AFD921BD48Q41828437-B338CF5D-C121-4B61-9A06-3A50A4C09E22Q41932899-EFEA83A3-AE10-49DE-B90E-7EC324E7027CQ41988138-993B053B-5159-4DFD-A63D-93E76C7C373AQ42031679-22A1B5A7-AA13-4AB1-90FF-89840E52C45DQ42140781-3511DAAE-D27F-4896-AD1A-C721D713C2B5Q42557083-6F4101FF-417A-4E33-8B88-541CF65E8C32Q44189842-D3F53079-FCF8-42B3-B975-48CEAE0A319BQ45209173-CDB02D61-B9EC-4927-9AD8-06EA1D29440EQ45375065-A932D5A8-CC6F-4FCC-A76F-060D66A556FCQ45409859-C452B3A7-3478-4784-8001-AC04C9905CE2Q45911018-E6F7F41F-47C5-4A49-A6C1-87251057F2ADQ46484624-B988074E-4940-4638-B016-551D2E71BFB4Q46513438-988917B5-A87A-4395-881C-25405662E549
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Oral strip technology: overview and future potential.
@ast
Oral strip technology: overview and future potential.
@en
Oral strip technology: overview and future potential.
@nl
type
label
Oral strip technology: overview and future potential.
@ast
Oral strip technology: overview and future potential.
@en
Oral strip technology: overview and future potential.
@nl
prefLabel
Oral strip technology: overview and future potential.
@ast
Oral strip technology: overview and future potential.
@en
Oral strip technology: overview and future potential.
@nl
P1476
Oral strip technology: overview and future potential.
@en
P2093
P304
P356
10.1016/J.JCONREL.2009.06.014
P407
P577
2009-06-24T00:00:00Z